294 related articles for article (PubMed ID: 32193420)
1. Mdm2 enhances ligase activity of parkin and facilitates mitophagy.
Kook S; Zhan X; Thibeault K; Ahmed MR; Gurevich VV; Gurevich EV
Sci Rep; 2020 Mar; 10(1):5028. PubMed ID: 32193420
[TBL] [Abstract][Full Text] [Related]
2. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy.
Cornelissen T; Haddad D; Wauters F; Van Humbeeck C; Mandemakers W; Koentjoro B; Sue C; Gevaert K; De Strooper B; Verstreken P; Vandenberghe W
Hum Mol Genet; 2014 Oct; 23(19):5227-42. PubMed ID: 24852371
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.
Bingol B; Tea JS; Phu L; Reichelt M; Bakalarski CE; Song Q; Foreman O; Kirkpatrick DS; Sheng M
Nature; 2014 Jun; 510(7505):370-5. PubMed ID: 24896179
[TBL] [Abstract][Full Text] [Related]
4. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin.
Durcan TM; Tang MY; Pérusse JR; Dashti EA; Aguileta MA; McLelland GL; Gros P; Shaler TA; Faubert D; Coulombe B; Fon EA
EMBO J; 2014 Nov; 33(21):2473-91. PubMed ID: 25216678
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide induction of Parkin translocation in PTEN-induced putative kinase 1 (PINK1) deficiency: functional role of neuronal nitric oxide synthase during mitophagy.
Han JY; Kang MJ; Kim KH; Han PL; Kim HS; Ha JY; Son JH
J Biol Chem; 2015 Apr; 290(16):10325-35. PubMed ID: 25716315
[TBL] [Abstract][Full Text] [Related]
6. Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.
Roverato ND; Sailer C; Catone N; Aichem A; Stengel F; Groettrup M
Cell Rep; 2021 Mar; 34(11):108857. PubMed ID: 33730565
[TBL] [Abstract][Full Text] [Related]
7. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
Koentjoro B; Park JS; Sue CM
Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
[TBL] [Abstract][Full Text] [Related]
8. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease.
Wang H; Song P; Du L; Tian W; Yue W; Liu M; Li D; Wang B; Zhu Y; Cao C; Zhou J; Chen Q
J Biol Chem; 2011 Apr; 286(13):11649-58. PubMed ID: 21292769
[TBL] [Abstract][Full Text] [Related]
9. Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1.
Glauser L; Sonnay S; Stafa K; Moore DJ
J Neurochem; 2011 Aug; 118(4):636-45. PubMed ID: 21615408
[TBL] [Abstract][Full Text] [Related]
10. AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease.
Haskin J; Szargel R; Shani V; Mekies LN; Rott R; Lim GG; Lim KL; Bandopadhyay R; Wolosker H; Engelender S
Hum Mol Genet; 2013 May; 22(10):2083-96. PubMed ID: 23393160
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism.
Narendra D; Walker JE; Youle R
Cold Spring Harb Perspect Biol; 2012 Nov; 4(11):. PubMed ID: 23125018
[TBL] [Abstract][Full Text] [Related]
12. SQSTM1/p62 promotes mitochondrial ubiquitination independently of PINK1 and PRKN/parkin in mitophagy.
Yamada T; Dawson TM; Yanagawa T; Iijima M; Sesaki H
Autophagy; 2019 Nov; 15(11):2012-2018. PubMed ID: 31339428
[TBL] [Abstract][Full Text] [Related]
13. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
Durcan TM; Fon EA
Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186
[TBL] [Abstract][Full Text] [Related]
14. Beyond Deubiquitylation: USP30-Mediated Regulation of Mitochondrial Homeostasis.
Hou J; Eldeeb M; Wang X
Adv Exp Med Biol; 2017; 1038():133-148. PubMed ID: 29178074
[TBL] [Abstract][Full Text] [Related]
15. Parkin, an E3 Ubiquitin Ligase, Plays an Essential Role in Mitochondrial Quality Control in Parkinson's Disease.
Wang XL; Feng ST; Wang ZZ; Yuan YH; Chen NH; Zhang Y
Cell Mol Neurobiol; 2021 Oct; 41(7):1395-1411. PubMed ID: 32623547
[TBL] [Abstract][Full Text] [Related]
16. Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson's disease.
Shiba-Fukushima K; Ishikawa KI; Inoshita T; Izawa N; Takanashi M; Sato S; Onodera O; Akamatsu W; Okano H; Imai Y; Hattori N
Hum Mol Genet; 2017 Aug; 26(16):3172-3185. PubMed ID: 28541509
[TBL] [Abstract][Full Text] [Related]
17. Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy.
Xian H; Liou YC
Autophagy; 2019 Dec; 15(12):2107-2125. PubMed ID: 30894073
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination.
Ahmed MR; Zhan X; Song X; Kook S; Gurevich VV; Gurevich EV
Biochemistry; 2011 May; 50(18):3749-63. PubMed ID: 21466165
[TBL] [Abstract][Full Text] [Related]
19. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
20. Parkin structure and function.
Seirafi M; Kozlov G; Gehring K
FEBS J; 2015 Jun; 282(11):2076-88. PubMed ID: 25712550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
